Investing.com - Adaptimmune Therapeutics reported on Monday first quarter earnings that beat analysts' forecasts and revenue that ...
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
